Published in Cell Immunol on May 01, 1978
The sequence of the human genome. Science (2001) 101.55
The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature (1997) 34.00
Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci U S A (1991) 5.46
Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes. Proc Natl Acad Sci U S A (1971) 5.38
Glucose transport in isolated brush border membrane from rat small intestine. J Biol Chem (1973) 4.75
The establishment of imitation and its use for the development of complex behavior in schizophrenic children. Behav Res Ther (1967) 4.02
Molecular genetic basis of allelic polymorphism in malate dehydrogenase (mdh) in natural populations of Escherichia coli and Salmonella enterica. Proc Natl Acad Sci U S A (1994) 3.90
Salmonella reference collection B (SARB): strains of 37 serovars of subspecies I. J Gen Microbiol (1993) 3.85
Relationship between evolutionary rate and cellular location among the Inv/Spa invasion proteins of Salmonella enterica. Proc Natl Acad Sci U S A (1995) 3.32
Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms. Int J Cancer (1971) 3.06
Reporting accuracy among mothers of malformed and nonmalformed infants. Am J Epidemiol (1989) 2.88
Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int J Cancer (1971) 2.88
Assessing pediatric anesthesia practices for volunteer medical services abroad. Anesthesiology (2001) 2.77
The work lives of women physicians results from the physician work life study. The SGIM Career Satisfaction Study Group. J Gen Intern Med (2000) 2.54
Ossifying fibroma: a clinicopathologic study of sixty-four cases. Oral Surg Oral Med Oral Pathol (1985) 2.38
Recombinational basis of serovar diversity in Salmonella enterica. Proc Natl Acad Sci U S A (1994) 2.35
Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. J Infect Dis (1987) 2.32
Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines. J Immunol (1989) 2.32
Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells. J Immunol (1988) 2.28
Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS (1995) 2.19
Children's knowledge of cancer and its treatment: impact of an oncology camp experience. J Pediatr (1990) 2.14
Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis (1997) 2.08
The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor. Ann Oncol (2012) 2.02
Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion. Proc Natl Acad Sci U S A (1980) 1.94
Transplantation methods as a tool for detection of tumor-specific antigens. Prog Exp Tumor Res (1965) 1.85
Elution of "blocking factors" from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes. Int J Cancer (1972) 1.76
Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites. J Acquir Immune Defic Syndr (2001) 1.63
Evolution of nuclear ribosomal RNAs in kinetoplastid protozoa: perspectives on the age and origins of parasitism. Proc Natl Acad Sci U S A (1993) 1.62
Specific killing of tumor cells in vitro in the presence of normal lymphoid cells and sera from hosts immune to the tumor antigens. Int J Cancer (1972) 1.60
Rapid changes in the concentration of phosphoenolpyruvate carboxykinase mRNA in rat liver and kidney. Effects of insulin and cyclic AMP. J Biol Chem (1982) 1.52
Production of TNF-alpha and TNF-beta by staphylococcal enterotoxin A activated human T cells. J Immunol (1990) 1.51
Evolutionary origin and radiation of the avian-adapted non-motile salmonellae. J Med Microbiol (1993) 1.50
Studies on mechanism of action of anti-tumor-promoting agents: their specificity in two-stage promotion. Proc Natl Acad Sci U S A (1980) 1.47
Needle-exchange attendance and health care utilization promote entry into detoxification. J Urban Health (1999) 1.47
WD40 repeat proteins striatin and S/G(2) nuclear autoantigen are members of a novel family of calmodulin-binding proteins that associate with protein phosphatase 2A. J Biol Chem (2000) 1.47
Chimeric peptides of statherin and osteopontin that bind hydroxyapatite and mediate cell adhesion. J Biol Chem (2000) 1.46
Declining seroprevalence and transmission of HTLV-I in Japanese families who immigrated to Hawaii. Am J Epidemiol (1991) 1.46
Strain measurement of abdominal aortic aneurysm with real-time 3D ultrasound speckle tracking. Eur J Vasc Endovasc Surg (2013) 1.45
Educational quality improvement report: outcomes from a revised morbidity and mortality format that emphasised patient safety. Qual Saf Health Care (2007) 1.44
14-3-3 proteins: potential roles in vesicular transport and Ras signaling in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1995) 1.43
Small-bowel obstruction and the effects of lidocaine, atropine and hexamethonium on inflammation and fluid losses. Acta Anaesthesiol Scand (1996) 1.42
Kinetics of IL-2 and interferon-gamma production, expression of IL-2 receptors, and cell proliferation in human mononuclear cells exposed to staphylococcal enterotoxin A. Cell Immunol (1985) 1.41
A kinetic and kinematic analysis of the Harai-goshi judo technique. Acta Physiol Hung (2001) 1.40
Occipital arteriovenous malformations: visual disturbances and presentation. Neurology (1996) 1.38
Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma. Int J Cancer (2000) 1.36
Two subsets of human CD4+ T helper cells differing in kinetics and capacities to produce interleukin 2 and interferon-gamma can be defined by the Leu-18 and UCHL1 monoclonal antibodies. Eur J Immunol (1988) 1.35
New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors. J Viral Hepat (2011) 1.35
The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor. Mol Cell Biol (1995) 1.32
Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma. Int J Cancer (1973) 1.30
Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of pharmacokinetics and pharmacodynamics. Br J Clin Pharmacol (1997) 1.30
A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells. J Immunol (1991) 1.29
Social support mediates the relationship between HIV stigma and depression/quality of life among people living with HIV in Beijing, China. Int J STD AIDS (2012) 1.29
Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling. Oncogene (2009) 1.28
Discrimination amongst Leishmania by polymerase chain reaction and hybridization with small subunit ribosomal DNA derived oligonucleotides. J Eukaryot Microbiol (1994) 1.27
Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity. Int J Cancer (1971) 1.27
Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab (2002) 1.25
Cytokine-induced Src homology 2 protein (CIS) promotes T cell receptor-mediated proliferation and prolongs survival of activated T cells. J Exp Med (2000) 1.24
Cross-reacting tumor-associated antigen (s) among chemically induced rat colon carcinomas. Cancer Res (1974) 1.24
The effect of gender on age-related blood pressure changes and the prevalence of isolated systolic hypertension among older adults: data from NHANES III. J Gend Specif Med (2001) 1.24
Demonstration of H-2 isoantigens and polyoma specific tumor antigens by measuring colony formation in vitro. Exp Cell Res (1965) 1.23
Biotransformation of terodiline. III. Opposed stereoselectivity in the benzylic and aromatic hydroxylations in rat liver microsomes. Xenobiotica (1987) 1.20
Interleukin 1 production by peripheral blood mononuclear cells from leprosy patients. Infect Immun (1984) 1.19
Increased SPARC expression promotes U87 glioblastoma invasion in vitro. Int J Dev Neurosci (1999) 1.18
Decline in deoxynivalenol (vomitoxin) concentrations in 1983 ontario winter wheat before harvest. Appl Environ Microbiol (1984) 1.17
Stimulation of human naive and memory T helper cells with bacterial superantigen. Naive CD4+45RA+ T cells require a costimulatory signal mediated through the LFA-1/ICAM-1 pathway. J Immunol (1992) 1.17
Mycobacterium tuberculosis disease in Somali immigrants in Minnesota. Chest (2001) 1.16
Molecular population genetic evidence of horizontal spread of two alleles of the pyrogenic exotoxin C gene (speC) among pathogenic clones of Streptococcus pyogenes. Infect Immun (1992) 1.16
Temporal variation in bacterial disease frequency: molecular population genetic analysis of scarlet fever epidemics in Ottawa and in eastern Germany. J Infect Dis (1993) 1.16
Increasing influenza immunization among high-risk patients: education or financial incentive? Am J Med (1996) 1.14
Characterization of individual tumor necrosis factor alpha-and beta-producing cells after polyclonal T cell activation. J Immunol Methods (1989) 1.14
Computer-generated mailed reminders for influenza immunization: a clinical trial. J Gen Intern Med (1992) 1.12
The effects of high-dose recombinant soluble CD4 on human immunodeficiency virus type 1 viremia. J Infect Dis (1994) 1.10
Phenotypic and genotypic characteristics of human immunodeficiency virus type 1 from patients with AIDS in northern Thailand. J Virol (1995) 1.10
Cloning and functional characterization of a subunit of the transporter associated with antigen processing. Proc Natl Acad Sci U S A (1997) 1.09
Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia. J Lab Clin Med (1997) 1.09
Fibrin adhesive system (FAS) influence on bone healing rate: a microradiographical evaluation using the bone growth chamber. Acta Orthop Scand (1982) 1.09
Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. Eur J Cancer (2003) 1.08
Sequential studies of serum blocking activity in rats bearing chemically induced primary bowel tumors. J Natl Cancer Inst (1975) 1.08
An outbreak of congenital rubella in Chicago. JAMA (1982) 1.08
Clinical pharmacokinetics of vasodilators. Part II. Clin Pharmacokinet (1998) 1.08
The syntagmatic-paradigmatic shift revisited: a review of research and theory. Psychol Bull (1977) 1.08
Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels. South Sweden Breast Cancer Group, and South-East Sweden Breast Cancer Group. Breast Cancer Res Treat (2000) 1.07
T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles. Crit Rev Immunol (1995) 1.07
Effects of BCG on various facets of the immune response against polyoma tumors in rats. Int J Cancer (1973) 1.06
A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4. Cancer (1991) 1.05
Cefprozil treatment of persistent and recurrent acute otitis media. Pediatr Infect Dis J (1997) 1.05
Induction of interleukin-1 in human monocytes by the superantigen staphylococcal enterotoxin A requires the participation of T cells. Cell Immunol (1991) 1.05
Subjects heterozygous for genetic loss of function of the thiazide-sensitive cotransporter have reduced blood pressure. Hum Mol Genet (2007) 1.04
Inhibition of the transcription factors AP-1 and NF-kappaB in CD4 T cells by peroxisome proliferator-activated receptor gamma ligands. Int Immunopharmacol (2001) 1.04
Induction of polyoma specific transplantation antigenicity in Moloney leukemia cells. Exp Cell Res (1965) 1.04
Separation of effector cells mediating antibody-dependent cellular cytotoxicity (ADC) to erythrocyte targets from those mediating ADC to tumor targets. J Immunol (1976) 1.04
A general, extracorporeal immunoadsorption method to increase the tumor-to-normal tissue ratio in radioimmunoimaging and radioimmunotherapy. J Nucl Med (1993) 1.04
Cholecystostomy for acute cholecystitis. Am J Surg (1973) 1.02
Serum mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomas. Cell Immunol (1970) 1.02
The Y chromosome: a graveyard for endogenous retroviruses. Gene (1995) 1.02
Spontaneous "high-pressure cerebrospinal rhinorrhea" due to lesions obstructing flow of cerebrospinal fluid. J Neurosurg (1969) 1.02
ErbB2 status and the benefit from two or five years of adjuvant tamoxifen in postmenopausal early stage breast cancer. Ann Oncol (2000) 0.99
Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer. Clin Cancer Res (2000) 0.99